Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors... by Jonas Ronn, Elisa P. Jensen, Nicolai J. Wewer Albrechtsen, Jens Juul Holst, Charlotte M. Sorensen

Subjects: “…Glucagon‐like peptide‐1…”
Get full text

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date by Howell R, Wright AM, Clements JN

Subjects: “…glucagon-like peptide-1…”
Get full text

Commentary on “Electroacupuncture Inhibited Spinal Glial Activation in Neuropathic Pain via Glucagon-like Peptide 1/Glucagon-like Peptide 1 Receptor Signaling” by Hulya Karatas

Subjects: Get full text

Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs by Sina A. Gharib, Rachna Vemireddy, Joseph J. Castillo, Brendy S. Fountaine, Theo K. Bammler, James W. MacDonald, Rebecca L. Hull-Meichle, Sakeneh Zraika

Subjects: Get full text

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects by Takaaki Murakami, Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu, Daisuke Yabe, Nobuya Inagaki

Subjects: Get full text

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells by Yun Kyung Jeon, Min Jung Bae, Ju In Kim, Joo Hyoung Kim, Soo Jong Choi, Su Kyoung Kwon, Joon Hyop An, Sang Soo Kim, Bo Hyun Kim, Yong Ki Kim, In Joo Kim

Subjects: “…Glucagon-like peptide 1…”
Get full text

Liraglutide Attenuates Aortic Valve Calcification in a High-Cholesterol-Diet-Induced Experimental Calcific Aortic Valve Disease Model in Apolipoprotein E-Deficient Mice by Yangzhao Zhou, Zhaoshun Yuan, Min Wang, Zhiyuan Zhang, Changming Tan, Jiaolian Yu, Yanfeng Bi, Xiaobo Liao, Xinmin Zhou, Md Sayed Ali Sheikh, Dafeng Yang

Subjects: Get full text

The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment by Baocheng Xie, Shichun Chen, Yongxiang Xu, Weichao Han, Runkai Hu, Minyi Chen, Yusheng Zhang, Shaobo Ding

Subjects: “…glucagon-like peptide-1…”
Get full text

The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesit... by Yuko Maejima, Shoko Yokota, Masaru Shimizu, Shoichiro Horita, Daisuke Kobayashi, Akihiro Hazama, Kenju Shimomura

Subjects: “…Glucagon-like peptide-1…”
Get full text

Dipeptidyl Peptidase‐4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress by Enbo Zhu, Lina Hu, Hongxian Wu, Limei Piao, Guangxian Zhao, Aiko Inoue, Weon Kim, Chenglin Yu, Wenhu Xu, Yasuko K. Bando, Xiang Li, Yanna Lei, Chang‐Ning Hao, Kyosuke Takeshita, Woo‐Shik Kim, Kenji Okumura, Toyoaki Murohara, Masafumi Kuzuya, Xian Wu Cheng

Subjects: “…glucagon‐like peptide‐1…”
Get full text

Imeglimin enhances glucagon secretion through an indirect mechanism and improves fatty liver in high‐fat, high‐sucrose diet‐fed mice by Osamu Kikuchi, Yuichi Ikeuchi, Masaki Kobayashi, Yoko Tabei, Hiromi Yokota‐Hashimoto, Tadahiro Kitamura

Subjects: Get full text

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists by Yu Mi Kang, Chang Hee Jung

Subjects: “…Glucagon-like peptide 1…”
Get full text

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes by Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich

Subjects: Get full text

Current and potential use of GLP-1R agonists: beyond type 2 diabetes by Graciela Zambrano-Galván, Ángel González-Romero, Miguel A. Reyes-Romero, Abelardo Camacho-Luis

Subjects: “…Glucagon-like peptide 1 receptor. Incretins. Pharmacological glucagon-like peptide 1 receptor agonists. …”
Get full text

Effects of GLP-1 Receptor Polymorphisms on Adolescent Obesity by Mahafarin Maralani, Tufan Cankaya, Esra Ataman, Yavuz Tokgoz, Erkan Kaytankas, Nur Arslan, Behzad Baradaran, Khalil Hajiasgharzadeh, Ayfer Ulgenalp

Subjects: “…Glucagon-like peptide-1…”
Get full text

Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label tri... by Yumie Takeshita, Yuki Kita, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Chisato Teramura, Yasufumi Enyama, Toshinari Takamura, the Establishment of Rationale for Antiaging Diabetic Medicine (ERA‐DM) Study Group

Subjects: “…Glucagon‐like peptide‐1 receptor agonists…”
Get full text

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity by Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto

Subjects: Get full text

Does combining liraglutide with intragastric balloon insertion improve sustained weight reduction? by Mahmoud M Mosli, Moaiad Elyas

Subjects: “…Glucagon-like peptide 1…”
Get full text

Relationship between diet/exercise and pharmacotherapy to enhance the GLP‐1 levels in type 2 diabetes by Yuki Fujiwara, Shunsuke Eguchi, Hiroki Murayama, Yuri Takahashi, Mitsutoshi Toda, Kota Imai, Kinsuke Tsuda

Subjects: Get full text

The benefits of GLP1 receptors in cardiovascular diseases by Lamija Ferhatbegović, Denis Mršić, Amra Macić-Džanković

Subjects: “…glucagon-like peptide-1…”
Get full text